A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples